Q2 26 EPS
$2.30
BEAT +2.94%
Est. $2.23
Q2 26 Revenue
$6.38B
MISS 3.32%
Est. $6.60B
vs S&P Since Q2 26
-20.4%
TRAILING MARKET
CTVA -16.3% vs S&P +4.1%
Market Reaction
Did CTVA Beat Earnings? Q2 2026 Results
Corteva, Inc. Delivered a mixed but ultimately encouraging second quarter for fiscal 2026, beating Wall Street's earnings expectations for the fourth consecutive quarter while falling short on revenue. The agricultural sciences company posted operati… Read more Corteva, Inc. Delivered a mixed but ultimately encouraging second quarter for fiscal 2026, beating Wall Street's earnings expectations for the fourth consecutive quarter while falling short on revenue. The agricultural sciences company posted operating EPS of $2.30, edging past the $2.23 consensus estimate by 2.94%, even as net sales slipped 1.2% year-over-year to $6.38 billion, coming in below the $6.60 billion analysts had anticipated. The earnings strength was driven primarily by the Seed segment, where operating EBITDA climbed 6% to $1.97 billion on flat sales, with price and mix gains of 3% from strong demand for differentiated seed technologies more than offsetting volume headwinds tied to corn-to-soy acreage shifts in North America. Crop Protection faced a tougher environment, with net sales declining 4% to $1.85 billion amid competitive pricing pressure in Latin America. Management raised full-year 2026 guidance to Operating EBITDA of $4.10 billion to $4.30 billion and Operating EPS of $3.60 to $3.80, while confirming the planned Vylor spin-off remains on track for October 1, 2026.
Key Takeaways
- • Demand for next-gen Seed technologies and differentiated germplasm
- • Price-for-value strategy execution driving Seed price/mix gains
- • Cost and productivity actions offsetting volume and price headwinds
- • Increased royalty/out-licensing income
- • Operating EBITDA margin expansion of over 190 basis points in Q2
CTVA Forward Guidance & Outlook
Corteva raised full-year 2026 guidance, now expecting Operating EBITDA of $4.1 billion to $4.3 billion (growth of 9% at the mid-point) and Operating EPS of $3.60 to $3.80 per share (growth of 11% at the mid-point). The increase reflects strong first-half execution, incremental benefits on controllable levers, and growth platforms. The company noted $25 million in net dis-synergy headwinds included in guidance due to separation timing. The overall agricultural landscape is characterized by strong demand, with farmers prioritizing investments that enhance productivity and returns. Seed demand continues to be supported by strong adoption of differentiated technologies, while Crop Protection benefits from normalized channel inventories and improving industry fundamentals. The company expects approximately $140–$150 million in net pre-tax restructuring charges during 2026 for Crop Protection network optimization. The planned Vylor separation remains on track for October 1, 2026.
CTVA YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
CTVA Revenue by Segment
With YoY comparisons, source: SEC Filings
CTVA Revenue by Geography
With YoY comparisons, source: SEC Filings
“Our strong first half was fueled by demand for next-gen Seed technologies, differentiated Crop Protection products, and focused execution. This level of performance, combined with our company-wide focus on productivity, cost discipline and operational excellence, allowed us to deliver continued margin expansion. Given these results, and our confidence in the opportunities ahead, we are raising our full-year guidance. We also continue to make meaningful progress toward the planned separation, an important milestone that will create two focused, industry-leading companies with enhanced strategic flexibility and ambition to continue to create sustainable value for farmers, customers, shareholders, and employees. As we begin the second half of the year, our focus remains where it should be: on our customers, on delivering the year and on ensuring the separation on October 1 is both timely and smooth. I'm excited to see what the future holds for both companies.”
— Chuck Magro, Q2 2026 Earnings Press Release
CTVA Earnings Trends
CTVA vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CTVA EPS Trend
Earnings per share: estimate vs actual
CTVA Revenue Trend
Quarterly revenue: estimate vs actual
CTVA Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q2 26 BEAT | $2.23 | $2.30 | +2.94% | $6.38B | -3.32% |
| Q1 26 BEAT | $1.18 | $1.50 | +27.11% | $4.91B | +5.77% |
| Q4 25 BEAT FY | $0.22 | $0.22 | +1.76% | $3.91B | -7.49% |
| FY Full Year | — | $3.34 | — | $17.40B | — |
| Q3 25 BEAT | $-0.47 | $-0.23 | +50.61% | $2.62B | +6.10% |
| Q2 25 BEAT | $1.88 | $2.20 | +17.09% | $6.46B | +2.97% |